European Neuropsychopharmacology
Volume 20, Issue 4 , Pages 272-275, April 2010

Deletion variant of α2b-adrenergic receptor gene moderates the effect of COMT val158met polymorphism on episodic memory performance

  • Ayana A. Gibbs

      Affiliations

    • Section of Cognitive Neuropsychiatry, Institute of Psychiatry, King's College London, United Kingdom
    • Corresponding Author InformationCorresponding author. Box PO68, Institute of Psychiatry, De Crespigny Park, London SE5 8AF, United Kingdom.
  • ,
  • Kris H. Naudts

      Affiliations

    • Department of Forensic Mental Health, Institute of Psychiatry, King's College London, United Kingdom
  • ,
  • Ruben T. Azevedo

      Affiliations

    • Section of Cognitive Neuropsychiatry, Institute of Psychiatry, King's College London, United Kingdom
  • ,
  • Anthony S. David

      Affiliations

    • Section of Cognitive Neuropsychiatry, Institute of Psychiatry, King's College London, United Kingdom

Received 21 July 2009; received in revised form 11 December 2009; accepted 24 December 2009. published online 28 January 2010.

Abstract 

The COMT val158 variant has been associated with impaired cognitive function compared to the met158 variant yet gene–gene interactions are not well described. In this study we demonstrate an interaction between this COMT polymorphism and a deletion variant of ADRA2B, the gene encoding the α2b-adrenergic receptor on episodic memory performance. Specifically, carriage of the ADRA2B deletion abolished the relative memory impairment in homozygous COMT val158 carriers compared to met158 carriers.

Keywords: Genetics, Emotional memory, Episodic memory, COMT, ADRA2B, Catecholamines, Noradrenaline

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0924-977X(10)00003-9

doi:10.1016/j.euroneuro.2009.12.007

European Neuropsychopharmacology
Volume 20, Issue 4 , Pages 272-275, April 2010